Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [Leuk Res. 2016 Jul;46:61-68.]

Leuk Res. 2019 Jun:81:107. doi: 10.1016/j.leukres.2017.06.012.

¹ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
² Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: xlh64@medmail.com.cn.

No abstract available

Publication types